DK2564396T3 - Fremgangsmåde til isotop-fremstilling - Google Patents

Fremgangsmåde til isotop-fremstilling

Info

Publication number
DK2564396T3
DK2564396T3 DK11719186.6T DK11719186T DK2564396T3 DK 2564396 T3 DK2564396 T3 DK 2564396T3 DK 11719186 T DK11719186 T DK 11719186T DK 2564396 T3 DK2564396 T3 DK 2564396T3
Authority
DK
Denmark
Prior art keywords
isotop
procedure
manufacturing
isotop manufacturing
Prior art date
Application number
DK11719186.6T
Other languages
English (en)
Inventor
Jan Roger Karlson
Rretzen Peer Bã
Original Assignee
Bayer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer As filed Critical Bayer As
Application granted granted Critical
Publication of DK2564396T3 publication Critical patent/DK2564396T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F13/00Compounds of radium
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005Isotope delivery systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • G21G2001/0094Other isotopes not provided for in the groups listed above

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Geology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
DK11719186.6T 2010-04-30 2011-04-29 Fremgangsmåde til isotop-fremstilling DK2564396T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201007354A GB201007354D0 (en) 2010-04-30 2010-04-30 Method
PCT/EP2011/002155 WO2011134671A1 (en) 2010-04-30 2011-04-29 Isotope preparation method

Publications (1)

Publication Number Publication Date
DK2564396T3 true DK2564396T3 (da) 2015-06-22

Family

ID=42289984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11719186.6T DK2564396T3 (da) 2010-04-30 2011-04-29 Fremgangsmåde til isotop-fremstilling

Country Status (23)

Country Link
US (3) US8926943B2 (da)
EP (2) EP2854137A1 (da)
JP (3) JP5973421B2 (da)
KR (2) KR101886884B1 (da)
CN (2) CN103003889B (da)
AU (1) AU2011247361B2 (da)
BR (1) BR112012027929B1 (da)
CA (1) CA2797898C (da)
DK (1) DK2564396T3 (da)
EA (2) EA022498B1 (da)
ES (1) ES2539135T3 (da)
GB (1) GB201007354D0 (da)
HK (2) HK1225851A1 (da)
HR (1) HRP20150577T1 (da)
IL (1) IL222763B (da)
MX (1) MX2012012670A (da)
NZ (2) NZ700258A (da)
PL (1) PL2564396T3 (da)
PT (1) PT2564396E (da)
RS (1) RS54089B1 (da)
SG (2) SG185105A1 (da)
SI (1) SI2564396T1 (da)
WO (1) WO2011134671A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
GB201007353D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
EP2934545A1 (en) 2012-12-19 2015-10-28 Bayer Pharma Aktiengesellschaft Combination comprising radium-223 for the treatment of cancer
GB201314718D0 (en) * 2013-08-16 2013-10-02 Algeta As Quantification method
CN105934256B (zh) 2013-12-03 2019-12-27 拜耳制药股份公司 Pi3k-抑制剂的组合产品
EP3077003A1 (en) 2013-12-03 2016-10-12 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
AU2015261131B2 (en) * 2014-05-13 2018-02-22 Paul Scherrer Institut Production of 43Sc radionuclide and radiopharmaceuticals thereof for use in Positron Emission Tomography
WO2016083739A1 (fr) 2014-11-26 2016-06-02 Rhodia Operations Composition de lanthane et d'actinium-227
GB201600154D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
GB201600153D0 (en) 2016-01-05 2016-02-17 Bayer As Isotope preparation method
AR110995A1 (es) 2017-02-24 2019-05-22 Bayer Ag Combinación de inhibidores de quinasa atr con sal de radio-223
RU2752845C1 (ru) * 2020-05-13 2021-08-11 Акционерное Общество "Наука И Инновации" Способ получения высокочистого радия-223

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US5246591A (en) * 1990-07-13 1993-09-21 Pact, Incorporated Separation of metal ions on an anion exchange resin by chromatographic elution
CA2123588A1 (en) * 1991-11-14 1993-05-27 Frederick C. Leung Method for diagnosing and treating cancer
CA2187285C (en) * 1995-03-03 2000-10-10 James M. Anderson, Jr. Apparatus/method for electrochemically modifying chromatographic material
US5809394A (en) 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
JP3832961B2 (ja) * 1998-03-10 2006-10-11 ユニチカ株式会社 ラジウム吸着剤の再生方法
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
CN1147602C (zh) * 2001-09-10 2004-04-28 中国原子能科学研究院 一种放射性同位素镉-109的制备工艺
US7157022B2 (en) 2002-09-30 2007-01-02 .Pg Research Foundation, Inc. Multivalent metal ion extraction using diglycolamide-coated particles
GB0308407D0 (en) * 2003-04-11 2003-05-21 Amersham Plc Method of obtaining 68 GA
MXPA05010804A (es) * 2003-04-15 2006-03-09 Algeta As Torio 227 para uso en radioterapia de enfermedades del tejido blando.
JP2005154700A (ja) * 2003-11-21 2005-06-16 Tatsuya Suzuki クラウンエーテル構造を官能基として側鎖に有するフェノール誘導体の有機高分子
TWI375660B (en) * 2004-01-22 2012-11-01 Semequip Inc Isotopically-enriched boranes and methods of preparing them
US20070009409A1 (en) * 2005-07-11 2007-01-11 Hariprasad Gali 212Bi or 213Bi Generator from supported parent isotope
DE102006008023B4 (de) * 2006-02-21 2008-05-29 Actinium Pharmaceuticals, Inc. Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets
WO2010001728A1 (ja) * 2008-06-30 2010-01-07 独立行政法人日本原子力研究開発機構 キレート交換樹脂を用いた放射性銅の分離方法
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method

Also Published As

Publication number Publication date
CN105654999A (zh) 2016-06-08
SI2564396T1 (sl) 2015-08-31
HK1183558A1 (zh) 2013-12-27
RS54089B1 (en) 2015-10-30
EP2564396A1 (en) 2013-03-06
IL222763B (en) 2020-04-30
AU2011247361B2 (en) 2014-09-18
SG185105A1 (en) 2012-12-28
EP2854137A1 (en) 2015-04-01
HK1225851A1 (zh) 2017-09-15
KR20130111931A (ko) 2013-10-11
EP2564396B1 (en) 2015-05-20
US20210387861A1 (en) 2021-12-16
US8926943B2 (en) 2015-01-06
JP5973421B2 (ja) 2016-08-23
KR101886884B1 (ko) 2018-08-08
CA2797898A1 (en) 2011-11-03
CN103003889A (zh) 2013-03-27
EA201291060A1 (ru) 2013-05-30
PL2564396T3 (pl) 2015-10-30
IL222763A0 (en) 2012-12-31
NZ700258A (en) 2014-12-24
JP2016156839A (ja) 2016-09-01
PT2564396E (pt) 2015-07-23
CN103003889B (zh) 2016-01-20
JP2013530384A (ja) 2013-07-25
BR112012027929B1 (pt) 2021-10-26
CA2797898C (en) 2018-10-09
US20150104386A1 (en) 2015-04-16
NZ603459A (en) 2014-10-31
CN105654999B (zh) 2019-01-04
MX2012012670A (es) 2013-03-08
SG10201503317RA (en) 2015-06-29
HRP20150577T1 (hr) 2015-08-14
WO2011134671A1 (en) 2011-11-03
JP2018159716A (ja) 2018-10-11
EA022498B1 (ru) 2016-01-29
US20130136690A1 (en) 2013-05-30
KR20180038575A (ko) 2018-04-16
ES2539135T3 (es) 2015-06-26
BR112012027929A2 (pt) 2017-03-21
EA201590442A1 (ru) 2015-11-30
GB201007354D0 (en) 2010-06-16

Similar Documents

Publication Publication Date Title
NL300940I2 (nl) emicizumab
BR112013009935C8 (pt) compostos
DK2564396T3 (da) Fremgangsmåde til isotop-fremstilling
BR112013003753A2 (pt) compostos
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
DK3225404T3 (da) Fluidpatron
CR20130111A (es) Triazina-oxidiazoles
DE10170954T8 (de) Mikrowellendruckgarer
DE112011104226A5 (de) Käfigmutter
DK3275896T3 (da) Fremgangsmåde til at opnå antistoffer
CO6801726A2 (es) Compuestos
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
FI20105720A0 (fi) Kaapeliläpivientilaippa
DK2649070T3 (da) Triazolpyridinforbindelser
DE112011101226A5 (de) Linearwegmesssystem
DE112011102080A5 (de) Kupplungszentralausrücker
DK2442899T3 (da) Rotorskive
DK2539163T3 (da) Dækventil
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011102711A5 (de) Hydrostataktor
DK2448659T3 (da) Rotorskive
DK2447426T3 (da) Vaske-WC
DE102010019119B8 (de) Cuttermesser